News
Greehey CCRI Receives Its First NIH K99 Award
Yu-Chiao Chiu, Ph.D., a postdoctoral researcher at the Greehey Children’s Cancer Research Institute (GCCRI), received the prestigious NIH Pathway to Independence Award (K99/R00) from the National Cancer Institute (NCI). The highly competitive NIH grant …
Manjeet Rao, Ph.D., Awarded NCI, R01 Grant to Test Efficacy of Novel Drug
Dr. Manjeet Rao, Greehey CCRI Deputy Director (interim), was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in …
Greehey CCRI Faculty Awarded $1.2M CPRIT Grant to Support Osteosarcoma Research
Written by: Will Sansom An award of $1.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) went to Greehey CCRI Deputy Director and principal investigator Manjeet Rao, Ph.D., professor of cell systems and anatomy, for studies o …
Luiz O.F. Penalva, Ph.D., Co-corresponding Senior Author on NPJ Genomic Medicine publication.
“Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles” Abstract Therapy resistance and recurrence in high-grade gliomas are driven by their populations of glioma stem cells (GSCs). Thus, detailed molecul …
BISHOP LAB: Pipette Gazette, Kevin Kanda, From Nursing Student To Graduate Student
Kevin Kanda made a promise to his family to try to fight cancer.
Adam Kosti from Penalva Lab Publishes First, First-Author Paper
ELF4 is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State Abstract 13-Cis-retinoic acid (RA) is typically used in postremission maintenance therapy in patients with neuroblastoma. However, side effects and recurren …